A detailed history of Carnegie Lake Advisors LLC transactions in Baxter International Inc stock. As of the latest transaction made, Carnegie Lake Advisors LLC holds 14,950 shares of BAX stock, worth $276,126. This represents 0.14% of its overall portfolio holdings.

Number of Shares
14,950
Previous 17,250 13.33%
Holding current value
$276,126
Previous $522,000 34.87%
% of portfolio
0.14%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$21.71 - $31.23 $49,933 - $71,829
-2,300 Reduced 13.33%
14,950 $340,000
Q2 2025

Aug 06, 2025

BUY
$27.8 - $34.02 $10,425 - $12,757
375 Added 2.22%
17,250 $522,000
Q1 2025

May 05, 2025

BUY
$29.26 - $36.57 $76,076 - $95,082
2,600 Added 18.21%
16,875 $578,000
Q4 2024

Jan 29, 2025

BUY
$28.63 - $37.84 $161,759 - $213,796
5,650 Added 65.51%
14,275 $416,000
Q3 2024

Nov 04, 2024

BUY
$32.85 - $40.26 $283,331 - $347,242
8,625 New
8,625 $327,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $9.31B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Carnegie Lake Advisors LLC Portfolio

Follow Carnegie Lake Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Lake Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Lake Advisors LLC with notifications on news.